Home › Funds › Ikarian Capital, LLC › FTH

Ikarian Capital, LLC position in FTH

FAETH THERAPEUTICS INC

Ikarian Capital, LLC reported holding 199,694 shares of FTH (FAETH THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$5.9M, representing 0.87% of its reported portfolio and ranking #30 among its reported holdings. Ikarian Capital, LLC has disclosed FTH holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)199.69K sh
Reported value held$5.94M
Portfolio Weight0.87%
First reportedQ2 2025
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Ikarian Capital, LLC's FTH position evolved

Ikarian Capital, LLC first disclosed a stake in FTH in Q2 2025 at 22,497 shares (US$193K). The position peaked in Q3 2026 at 199,694 shares, worth US$5.9M. Across 6 filings, Ikarian Capital, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 199,694 shares valued at US$5.9M — an increase of 164,308 shares quarter over quarter.. Notable position changes include a 70% trim in Q1 2026 (shares fell 21% over the following quarter), a 457% increase in Q2 2026 (shares rose 19% over the following quarter), a 464% increase in Q3 2026 (shares fell 69% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 22.50K $193.03K New
Q3 2025 22.50K $212.60K Hold
Q4 2025 21.35K $227.81K Reduce
Q1 2026 6.35K $200.18K Reduce
Q2 2026 35.39K $884.65K Add
Q3 2026 199.69K $5.94M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About FTH and 13F data

FTH (FAETH THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 78 other funds we track also report a position in FTH — the largest reported positions include MONTANOVA CAPITAL, LLC (US$68.7M), Avoro Capital Advisors LLC (US$41.9M), Cormorant Asset Management, LP (US$30.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding FTH

All FTH fund holders →

FAQ

How long has Ikarian Capital, LLC held FTH?

Ikarian Capital, LLC has disclosed FTH holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Ikarian Capital, LLC's current position in FTH?

As of Q3 2026, Ikarian Capital, LLC holds 199.69K shares of FTH (FAETH THERAPEUTICS INC), valued at $5.94M, representing 0.87% of its reported portfolio and ranking #30.

Has Ikarian Capital, LLC been buying or selling FTH?

In the latest 13F filing (Q3 2026), Ikarian Capital, LLC increased its position in FTH. The position peaked in Q3 2026 at 199.69K shares.

Which other funds hold FTH?

Other major institutional holders of FTH include MONTANOVA CAPITAL, LLC, Avoro Capital Advisors LLC, Cormorant Asset Management, LP, among 78 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.